Astrazeneca Pharma India Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Astrazeneca Pharma India Ltd with three other
companies in this sector in India:
Neuland Laboratories Limited
sales of 5.73 billion Indian Rupees [US$88.20 million]
Morepen Laboratories Limited
(5.84 billion Indian Rupees [US$89.92 million]
of which 100%
was Pharmaceuticals), and
Suven Life Sciences Limited
(5.44 billion Indian Rupees [US$83.70 million]
of which 95%
was Intermediaries under Contract Research/M).
During the year ended March of 2017, sales at
Astrazeneca Pharma India Ltd were 5.40 billion Indian Rupees (US$83.09 million).
decrease of 4.3%
versus 2016, when the company's sales were 5.64 billion Indian Rupees.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Astrazeneca Pharma India Ltd had sales
of 5.31 billion Indian Rupees.
Contributing to the drop in overall sales was the 6.5% decline
in Healthcare, from 5.54 billion Indian Rupees to 5.18 billion Indian Rupees.
However, these declines were partially offset by the increase in sales of
Others (up 123.0% to 216.38 million Indian Rupees)